I remember vividly the moment that the thought took root. A young man from out of
state had been admitted to our service with dermatomyositis that had not responded
well to initial therapy. His disease was unusually severe, and his weakness had progressed
rapidly, leaving him almost incapable of independent motor activity, and unable to
swallow, with attendant, profound weight loss. The patient had graduated from college
only 8 months earlier, in excellent health. Shortly after graduation, microscopic
hematuria was noted, and work-up revealed a small renal cancer. He underwent nephrectomy,
and recuperated well, starting a new job in the early summer. He was asymptomatic
upon his return home to celebrate Thanksgiving, where he played football with his
family and friends in a friendly but physically very strenuous game. Within weeks,
the patient noticed the onset of proximal muscle weakness, which worsened and became
disabling over a 6-week period, and affected his swallowing. The literature was already
replete with epidemiological analyses demonstrating a higher incidence of cancer in
dermatomyositis,
1
,
2
,
3
with cancer diagnosis clustering in the several years around the time of diagnosis
of the rheumatic diseases, but this patient's story stopped me cold. Here was amazing
immune power unleashed against muscle, in the setting of a recent cancer and immediately
preceded by unusually strenuous exercise. Striking stories like this allow previously
hidden patterns in additional diseases to become evident. Take, for example, the nurse
who presented with small cell lung cancer, followed a year later by signs of diffuse
scleroderma. Were these narratives hinting at an unexpected biological structure underlying
myositis and other rheumatic diseases, in which cancer precedes autoimmunity, and
may initiate and drive tissue damage in rheumatic diseases?To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.N Engl J Med. 1992; 326: 363-367
- Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.Lancet. 2001; 357: 96-100
- Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study.Ann Intern Med. 2001; 134: 1087-1095
- A new initiative on precision medicine.N Engl J Med. 2015; 372: 793-795
- Chauvinism in Medicine. An Address Before the Canadian Medical Association, Montreal, September 17, 1902.in: McGovern J.P. Roland C.G. The Collected Essays of Sir William Osler. The Classics of Medicine Library, Birmingham, Ala1985 (Vol. 1)
- Autoantigens as partners in initiation and propagation of autoimmune rheumatic diseases.Annu Rev Immunol. 2016; 34: 395-420
- Association of the autoimmune disease scleroderma with an immunologic response to cancer.Science. 2014; 343: 152-157
- Review: cancer-induced autoimmunity in the rheumatic diseases.Arthritis Rheumatol. 2015; 67: 317-326
Article info
Publication history
Published online: February 26, 2018
Footnotes
Funding: None.
Conflicts of Interest: None.
Authorship: I declare that I am the sole author and responsible for all content.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.